Company intelligence / Profile preview

CentricsBio

Seoul / Songpa-gu, Munjeong-dong, Seoul, Korea, Republic of / South Koreacentricsbio.com ↗

Ownership: Private
Development stage: Other

Overview

CentricsBio is developing monoclonal antibody therapeutics targeting CD300c for both oncology and neurodegenerative diseases. Their lead program CB301 targets solid tumors by activating macrophages to enhance anti-tumor immunity. CB201 aims to treat Alzheimer’s disease by promoting amyloid beta clearance via activated macrophages. The company has reported promising in vivo animal data and is entering GLP toxicology studies as of mid/late 2025. Programs for autoimmune diseases are also in preclinical development.

Therapeutic areas: OncologyImmunologyNeurology
Modalities: Monoclonal antibodyBiological productsCAR-T
Industry: Biotech

Drug pipeline

6 assets

CB201

Preclinical

5 more assets in the full pipeline.

Partnerships

Cha University Bundang Medical Center (collaborative research contract)Networks with leading domestic and overseas research institutes

Beyond the preview

Go deeper on CentricsBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CentricsBio.